309 related articles for article (PubMed ID: 29971600)
21. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
[TBL] [Abstract][Full Text] [Related]
22. RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy.
Ribeiro M; Furtado M; Martins S; Carvalho T; Carmo-Fonseca M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079122
[TBL] [Abstract][Full Text] [Related]
23. Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs.
Montag J; Petersen B; Flögel AK; Becker E; Lucas-Hahn A; Cost GJ; Mühlfeld C; Kraft T; Niemann H; Brenner B
Sci Rep; 2018 Mar; 8(1):4786. PubMed ID: 29555974
[TBL] [Abstract][Full Text] [Related]
24. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
25. The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy.
Jørgenrud B; Jalanko M; Heliö T; Jääskeläinen P; Laine M; Hilvo M; Nieminen MS; Laakso M; Hyötyläinen T; Orešič M; Kuusisto J
PLoS One; 2015; 10(8):e0134184. PubMed ID: 26267065
[TBL] [Abstract][Full Text] [Related]
26. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
[TBL] [Abstract][Full Text] [Related]
27. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
28. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
[TBL] [Abstract][Full Text] [Related]
30. Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice.
Mearini G; Stimpel D; Geertz B; Weinberger F; Krämer E; Schlossarek S; Mourot-Filiatre J; Stoehr A; Dutsch A; Wijnker PJ; Braren I; Katus HA; Müller OJ; Voit T; Eschenhagen T; Carrier L
Nat Commun; 2014 Dec; 5():5515. PubMed ID: 25463264
[TBL] [Abstract][Full Text] [Related]
31. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
[TBL] [Abstract][Full Text] [Related]
33. Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology.
Carrier L; Mearini G; Stathopoulou K; Cuello F
Gene; 2015 Dec; 573(2):188-97. PubMed ID: 26358504
[TBL] [Abstract][Full Text] [Related]
34. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
[TBL] [Abstract][Full Text] [Related]
35. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic cardiomyopathy: from gene defect to clinical disease.
Chung MW; Tsoutsman T; Semsarian C
Cell Res; 2003 Feb; 13(1):9-20. PubMed ID: 12643345
[TBL] [Abstract][Full Text] [Related]
37. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
[TBL] [Abstract][Full Text] [Related]
38. Modeling Hypertrophic Cardiomyopathy: Mechanistic Insights and Pharmacological Intervention.
Mosqueira D; Smith JGW; Bhagwan JR; Denning C
Trends Mol Med; 2019 Sep; 25(9):775-790. PubMed ID: 31324451
[TBL] [Abstract][Full Text] [Related]
39. Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.
Liu X; Jiang T; Piao C; Li X; Guo J; Zheng S; Zhang X; Cai T; Du J
Sci Rep; 2015 Jun; 5():11411. PubMed ID: 26090888
[TBL] [Abstract][Full Text] [Related]
40. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]